Tag Archives: mitral valve

La reparación de la válvula mitral con Mitraclip es segura en pacientes de alto riesgo

Mitral Valve Repair with MitraClip Is Safe in High-Risk Patients

Mitral Valve Repair with MitraClip Is Safe in High-Risk Patients

Courtesy of Dr. Carlos Fava. Transcatheter mitral valve repair with MitraClip has shown good results in symptomatic patients with extreme surgical risk in different studies. However, its “real world” benefits have not been studied in depth due to how complex this strategy is compared with other usual procedures. This study analyzed 2952 patients who underwent mitral

SOLACI CACI 2017 | Perspectives of Transcatheter mitral valve replacement (TMVR): early data

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. José Luis Navia, entitled “Perspectives of Transcatheter mitral valve replacement (TMVR): early data”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

SOLACI CACI 2017 | Clinical results of Mitraclip in degenerative mitral valve regurgitation

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Samir Kapadia, entitled “Clinical results of Mitraclip in degenerative mitral valve regurgitation”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

valvula-mitral-protesica

SOLACI CACI 2017 | The Mitral Revolution: Emerging Data and Future Trends

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Juan Granada entitled “The Mitral Revolution: Emerging Data and Future Trends”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

SOLACI CACI 2017 | New horizons in percutaneous mitral valve implantation

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Eduardo de Marchena, entitled “New horizons in percutaneous mitral valve implantation”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

MitraClip: ¿debemos intervenir antes a nuestros pacientes?

MitraClip: Should We Intervene Earlier?

Courtesy of Dr. Carlos Fava. Repairing the mitral valve with Mitraclip has become an alternative for high risk or inoperable symptomatic patients, but its long term evolution has only been tested by the EVEREST II, which had not taken into account 5 year mortality outcomes. Therefore, to better study its evolution, we need to carry out different randomized studies

reemplazo valvular mitral por catéter por enfermedad de la válvula nativa

Mitral Valve Global Registry: transcatheter mitral valve replacement due to native valve disease

Courtesy of the SBHCI. The risk of surgical mitral valve replacement in patients with significant annular calcification is very high. There are isolated reports of transcatheter mitral valve replacement with balloon-expandable valve in this patient population. In consequence, this multicenter registry tries to concentrate information and analyzes the outcomes a year after the procedure.  

reemplazo valvular mitral por cateter en insuficiencia mitral sintomática

Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: A Global Study

Symptomatic mitral regurgitation is associated with high morbidity and mortality that can be alleviated partly by surgical mitral valve replacement. However, many patients do not undergo surgery. Transcatheter mitral valve replacement is an appealing option for this selected patient group.   This study aimed to examine the effectiveness and safety of transcatheter mitral valve replacement

anuloplastia mitral insuficiencia mitral

Mitral Annuloplasty with a Cardioband Device: Effective in Functional Mitral Regurgitation

Both surgical and medical treatment options for functional mitral regurgitation are limited. The Cardioband system (Valtech Cardio, OrYehuda, Israel) is a new transvenous, transseptal direct mitral annuloplasty device. This work studied the safety and efficacy of this new device 6 months after implantation.   Thirty-one patients with moderate to severe mitral regurgitation associated with severe impairment of the left systolic ventricular

Transcatheter Mitral Valve Replacement

Transcatheter Mitral Valve Replacement: A New Arrow in the Bow

Original Title: Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry Reference: J Am Coll Cardiol Intv. 2016;9(13):1361-1371. doi:10.1016/j.jcin.2016.04.022 Gentileza del Dr. Agustín Vecchia. The risk underlying the surgical approach to mitral valve replacement in patients with severe mitral annular calcification is high. A

Top